* If the product has intellectual property rights, a license granted is must or contact us.
Introduction of 1029692-15-6 :
LY2452473 is an orally bioavailable, selective androgen receptor modulator (SARM). IC50 & Target: Androgen receptorIn Vivo: LY2452473 is a selective androgen receptor modulator being developed for the treatment of disorders related to hypogonadism. LY2452473 is absorbed rapidly (time to reach maximum plasma concentration for both LY2452473 and total radioactivity is 2-3 h) and cleared slowly (plasma terminal t1/2 of 27 h for LY2452473 and 51 h for the total radioactivity).